Eosinophilia and progression to active tuberculosis in HIV-1-infected Ugandans

被引:21
|
作者
Elliott, AM
Kyosiimire, J
Quigley, MA
Nakiyingi, J
Watera, C
Brown, M
Joseph, S
French, N
Gilks, CF
Whitworth, JAG
机构
[1] Uganda Virus Res Inst, Entebbe, Uganda
[2] Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England
[3] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England
[4] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England
[5] Univ London Imperial Coll Sci Technol & Med, Dept Med, London W2 1PG, England
关键词
tuberculosis; HIV; eosinophilia; Uganda;
D O I
10.1016/S0035-9203(03)90096-4
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
It has been suggested that type 1 immune responses protect against tuberculosis (TB), while type 2 responses, such as those induced by helminths, may suppress protective responses and increase susceptibility to TB. Factors associated with progression to active TB were investigated in a cohort of HIV-1-infected Ugandan adults, a group at high risk of TB. High rates of subsequent progression to active TB were associated with eosinophil counts greater than or equal to 0.4 x 10(9)/L at enrolment. Eosinophilia at enrolment was associated with male gender, low socio-economic status, high CD4+ T cell counts, and schistosomiasis, but adjusting for these factors did not explain the association of eosinophilia with progression to active TB (adjusted rate ratio = 2.76, P = 0.004). Eosinophilia is most likely to be indicative of a type 2 immune response induced by helminth infection in this Ugandan cohort, but the mechanism of the observed association between eosinophilia and risk of TB remains to be determined.
引用
收藏
页码:477 / 480
页数:4
相关论文
共 50 条
  • [41] Gender differences in clinical progression of HIV-1-infected individuals during long-term highly active antiretroviral therapy
    Nicastri, E
    Angeletti, C
    Palmisano, L
    Sarmati, L
    Chiesi, A
    Geraci, A
    Andreoni, M
    Vella, S
    AIDS, 2005, 19 (06) : 577 - 583
  • [42] Elevated Aspergillus-specific antibody levels among HIV infected Ugandans with pulmonary tuberculosis
    Kwizera, Richard
    Parkes-Ratanshi, Rosalind
    Page, Iain D.
    Sekaggya-Wiltshire, Christine
    Musaazi, Joseph
    Fehr, Jan
    Castelnuovo, Barbara
    Kambugu, Andrew
    Denning, David W.
    BMC PULMONARY MEDICINE, 2017, 17
  • [43] The Clinical Care of the HIV-1-Infected Infant
    Camacho-Gonzalez, Andres F.
    Ross, Allison C.
    Chakraborty, Rana
    CLINICS IN PERINATOLOGY, 2010, 37 (04) : 873 - +
  • [44] MODE OF DELIVERY IN HIV-1-INFECTED WOMEN
    FUITH, LC
    CZARNECKI, M
    WACHTER, H
    FUCHS, D
    LANCET, 1992, 339 (8809): : 1603 - 1603
  • [45] Neuroimaging in the brain in HIV-1-infected patients
    Thurnher, Majda M.
    Post, M. Judith Donovan
    NEUROIMAGING CLINICS OF NORTH AMERICA, 2008, 18 (01) : 93 - +
  • [46] Cardiac transplantation in an HIV-1-infected patient
    Morgan, JA
    Bisleri, G
    Mancini, DM
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (14): : 1388 - 1389
  • [47] Nevirapine use in HIV-1-infected children
    Verweel, G
    Sharland, M
    Lyall, H
    Novelli, V
    Gibb, DM
    Dumont, G
    Ball, C
    Wilkins, E
    Walters, S
    Tudor-Williams, G
    AIDS, 2003, 17 (11) : 1639 - 1647
  • [48] Renal dysfunction in HIV-1-infected patients
    Jeffrey B. Kopp
    Current Infectious Disease Reports, 2002, 4 (5) : 449 - 460
  • [49] Vaccination recommendations for HIV-1-infected children
    Papaevangelou, V
    Borkowsky, W
    CLINICAL IMMUNOTHERAPEUTICS, 1996, 5 (01): : 5 - 12
  • [50] Myelodysplastic syndrome in an HIV-1-infected infant
    van den Berg, H
    Scherpbier, HJ
    Kroes, W
    MEDICAL AND PEDIATRIC ONCOLOGY, 1999, 32 (05): : 385 - 385